v3.26.1
Shareholders' Equity
6 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
Shareholders' equity

9. Shareholders’ equity

 

 

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Authorized, allotted, called up and fully paid ordinary shares, par value
   £
0.05

 

 

10,292

 

 

 

10,290

 

 

Number

 

 

Number

 

Number of shares in issue

 

 

141,739,180

 

 

 

141,701,848

 

Number of equivalent ADSs in issue

 

 

47,246,393

 

 

 

47,233,949

 

 

The Group has only one class of shares. All ordinary shares have equal voting rights and rank pari passu for the distribution of dividends.

In March 2026, the Company entered into an Open Market Sale Agreement, or the Sales Agreement, with Jefferies LLC, or Jefferies, as sales agent, pursuant to which the Company may offer and sell, from time to time through Jefferies, at its option, its ordinary shares. The Company agreed to pay Jefferies a commission of up to 3.0% of the aggregate gross proceeds for the ordinary shares sold through the Sales Agreement. During the three months ended June 30, 2026, no sales were made under the Sales Agreement.

Details of the shares issued during the current three months and prior year are as follows:

 

Number of shares in issue at January 1, 2025

 

 

141,674,074

 

Number of ADSs in issue at January 1, 2025

 

 

47,224,691

 

Shares issued during the year

 

 

 

Options exercised at $0.20/ADS or $0.07/ordinary share

 

 

17,775

 

Options exercised at $4.23/ADS or $1.41/ordinary share

 

 

9,999

 

Number of shares in issue at December 31, 2025

 

 

141,701,848

 

Number of equivalent ADSs in issue at December 31, 2025

 

 

47,233,949

 

 

 

 

 

 

 

 

 

Number of shares in issue at January 1, 2026

 

 

141,701,848

 

Number of ADSs in issue at January 1, 2026

 

 

47,233,949

 

Options exercised at $0.20/ADS or $0.07/ordinary share

 

 

7,491

 

Options exercised at $4.48/ADS or $1.49/ordinary share

 

 

8,838

 

Options exercised at $7.19/ADS or $2.40/ordinary share

 

 

21,000

 

Options exercised at $9.98/ADS or $3.33/ordinary share

 

 

3

 

Number of shares in issue at June 30, 2026

 

 

141,739,180

 

Number of equivalent ADSs in issue at June 30, 2026

 

 

47,246,393

 

 

The Group has outstanding ADSs and each ADS represents three ordinary shares.